{"id":11789,"date":"2023-04-26T07:37:17","date_gmt":"2023-04-26T05:37:17","guid":{"rendered":"https:\/\/ggba.swiss\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/"},"modified":"2023-07-04T13:44:17","modified_gmt":"2023-07-04T11:44:17","slug":"siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/","title":{"rendered":"Siegfried construit un centre mondial de R&D pour les substances m\u00e9dicamenteuses \u00e0 Evionnaz"},"content":{"rendered":"\n

Siegfried<\/a>, une entrprise mondiale de premier plan sp\u00e9cialis\u00e9e dans le d\u00e9veloppement et la fabrication \u00e0 fa\u00e7on (CDMO), a officiellement lanc\u00e9 la construction de son nouveau centre mondial de recherche et d\u00e9veloppement (R&D) pour les substances m\u00e9dicamenteuses sur son site d’Evionnaz. L’installation, qui doit commencer ses activit\u00e9s en 2024, travaillera en tandem avec le centre de R&D de Zofingen pour augmenter consid\u00e9rablement la capacit\u00e9 de R&D de Siegfried et stimuler sa croissance future.<\/p>\n

L’entreprise investira jusqu’\u00e0 CHF 25 millions dans le nouveau centre de R&D, o\u00f9 plus de 100 sp\u00e9cialistes hautement qualifi\u00e9s collaboreront avec les clients de Siegfried pour amener des produits innovants \u00e0 l’\u00e9chelle industrielle. Le centre disposera d’installations chimiques et analytiques avanc\u00e9es, de laboratoires ultramodernes et offrira des services de R&D en processus chimiques et de d\u00e9veloppement analytique pour l’ensemble du r\u00e9seau de substances m\u00e9dicamenteuses. Ce projet r\u00e9affirme l’engagement de Siegfried envers son site d’Evionnaz en tant que structure essentielle de son r\u00e9seau mondial de substances m\u00e9dicamenteuses.<\/p>\n

Siegfried a choisi le canton du Valais comme emplacement pour son nouveau centre mondial de R&D en raison de son importance strat\u00e9gique au sein du r\u00e9seau de l’entreprise et de sa pr\u00e9sence de longue date dans la r\u00e9gion. Le Valais offre un cadre id\u00e9al pour le centre de R&D, avec sa solide r\u00e9putation dans l’industrie des sciences de la vie, sa main-d’\u0153uvre qualifi\u00e9e et sa proximit\u00e9 avec des institutions de recherche renomm\u00e9es. L’emplacement b\u00e9n\u00e9ficie \u00e9galement de l’infrastructure et de l’accessibilit\u00e9 de la r\u00e9gion, permettant une collaboration et un \u00e9change efficaces avec les partenaires et clients mondiaux de Siegfried.<\/p>\n

Un jalon important pour la strat\u00e9gie de croissance de Siegfried<\/h4>\n

Wolfgang Wienand, CEO de Siegfried, a soulign\u00e9 l’importance du nouveau centre de R&D \u00e0 Evionnaz pour le r\u00e9seau mondial de l’entreprise et son engagement \u00e0 fournir des services de recherche et de d\u00e9veloppement avanc\u00e9s \u00e0 ses clients. Il a d\u00e9clar\u00e9 que le centre repr\u00e9sente une \u00e9tape importante dans la strat\u00e9gie de croissance de Siegfried et un pas consid\u00e9rable vers la position de leader dans l’espace CDMO.<\/p>\n

Siegfried se sp\u00e9cialise dans la fabrication d’ingr\u00e9dients pharmaceutiques actifs (API) et de leurs interm\u00e9diaires, ainsi que de produits m\u00e9dicamenteux tels que comprim\u00e9s, g\u00e9lules, flacons st\u00e9riles, ampoules, cartouches et onguents pour l’industrie pharmaceutique. En 2022, l’entreprise a r\u00e9alis\u00e9 un chiffre d’affaires de CHF 1,229 milliard et employ\u00e9 plus de 3\u2019600 personnes sur onze sites r\u00e9partis sur trois continents.<\/p>\n","protected":false},"excerpt":{"rendered":"

Siegfried cr\u00e9era un nouveau centre mondial de R&D \u00e0 Evionnaz, investissant CHF 25 millions pour renforcer ses capacit\u00e9s, stimuler la croissance et cr\u00e9er plus de 100 emplois qualifi\u00e9s.<\/p>\n","protected":false},"author":3,"featured_media":11790,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1054,1069],"class_list":["post-11789","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-investment-fr","tag-pharma-fr"],"acf":[],"yoast_head":"\nSiegfried construit un centre mondial de R&D pour les substances m\u00e9dicamenteuses \u00e0 Evionnaz - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Siegfried construit un centre mondial de R&D pour les substances m\u00e9dicamenteuses \u00e0 Evionnaz - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"Siegfried cr\u00e9era un nouveau centre mondial de R&D \u00e0 Evionnaz, investissant CHF 25 millions pour renforcer ses capacit\u00e9s, stimuler la croissance et cr\u00e9er plus de 100 emplois qualifi\u00e9s.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-26T05:37:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:44:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Siegfried-630x380-1-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Siegfried construit un centre mondial de R&D pour les substances m\u00e9dicamenteuses \u00e0 Evionnaz\",\"datePublished\":\"2023-04-26T05:37:17+00:00\",\"dateModified\":\"2023-07-04T11:44:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/\"},\"wordCount\":474,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Siegfried-630x380-1-2.png\",\"keywords\":[\"Investment\",\"Pharma\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/\",\"name\":\"Siegfried construit un centre mondial de R&D pour les substances m\u00e9dicamenteuses \u00e0 Evionnaz - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Siegfried-630x380-1-2.png\",\"datePublished\":\"2023-04-26T05:37:17+00:00\",\"dateModified\":\"2023-07-04T11:44:17+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Siegfried-630x380-1-2.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Siegfried-630x380-1-2.png\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Siegfried construit un centre mondial de R&D pour les substances m\u00e9dicamenteuses \u00e0 Evionnaz\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Siegfried construit un centre mondial de R&D pour les substances m\u00e9dicamenteuses \u00e0 Evionnaz - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/","og_locale":"fr_FR","og_type":"article","og_title":"Siegfried construit un centre mondial de R&D pour les substances m\u00e9dicamenteuses \u00e0 Evionnaz - Greater Geneva Bern area","og_description":"Siegfried cr\u00e9era un nouveau centre mondial de R&D \u00e0 Evionnaz, investissant CHF 25 millions pour renforcer ses capacit\u00e9s, stimuler la croissance et cr\u00e9er plus de 100 emplois qualifi\u00e9s.","og_url":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-04-26T05:37:17+00:00","article_modified_time":"2023-07-04T11:44:17+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Siegfried-630x380-1-2.png","type":"image\/png"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Siegfried construit un centre mondial de R&D pour les substances m\u00e9dicamenteuses \u00e0 Evionnaz","datePublished":"2023-04-26T05:37:17+00:00","dateModified":"2023-07-04T11:44:17+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/"},"wordCount":474,"image":{"@id":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Siegfried-630x380-1-2.png","keywords":["Investment","Pharma"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/","url":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/","name":"Siegfried construit un centre mondial de R&D pour les substances m\u00e9dicamenteuses \u00e0 Evionnaz - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Siegfried-630x380-1-2.png","datePublished":"2023-04-26T05:37:17+00:00","dateModified":"2023-07-04T11:44:17+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Siegfried-630x380-1-2.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Siegfried-630x380-1-2.png","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/siegfried-construit-un-centre-mondial-de-rd-pour-les-substances-medicamenteuses-a-evionnaz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Siegfried construit un centre mondial de R&D pour les substances m\u00e9dicamenteuses \u00e0 Evionnaz"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=11789"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11789\/revisions"}],"predecessor-version":[{"id":18360,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11789\/revisions\/18360"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/11790"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=11789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=11789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=11789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}